Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DMK65T
|
|||
| Drug Name |
Longeveron Mesenchymal Stem Cells
|
|||
| Synonyms |
LMSC
Click to Show/Hide
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Frailty [ICD-11: MG2A; ICD-10: R54] | Phase 1/2 | [1] | |
| Hypoplastic left heart syndrome [ICD-11: LA89.3; ICD-10: Q23.4] | Phase 1/2 | [2] | ||
| Company |
Longeveron Miami, Fl
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02982915) Human Mesenchymal Stem Cells (LMSCs) on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty (HERA). U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT03525418) Longeveron Mesenchymal Stem Cells (LMSCs) Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS) (ELPIS). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.